ICH guideline Q3D (R1) on elemental impurities (2018 – EMA) – Free PDF Download

Manostaxx
Manostaxx

 

http://www.manostaxx.com

 

 

Elemental impurities in drug products may arise from several sources; they may be residual catalysts
that were added intentionally in synthesis or may be present as impurities (e.g., through interactions  with processing equipment or container/closure systems or by being present in components of the drug  product). Because elemental impurities do not provide any therapeutic benefit to the patient, their  levels in the drug product should be controlled within acceptable limits. There are three parts of this guideline: the evaluation of the toxicity data for potential elemental impurities; the establishment of a Permitted Daily Exposure (PDE) for each element of toxicological concern; and application of a risk based approach to control elemental impurities in drug products. An applicant is not expected to  tighten the limits based on process capability, provided that the elemental impurities in drug products  do not exceed the PDEs. The PDEs established in this guideline are considered to be protective of  public health for all patient populations. In some cases, lower levels of elemental impurities may be  warranted when levels below toxicity thresholds have been shown to have an impact on other quality  attributes of the drug product (e.g., element catalyzed degradation of drug substances). In addition,  for elements with high PDEs, other limits may have to be considered from a pharmaceutical quality  perspective and other guidelines should be consulted (e.g., ICH Q3A).
This guideline presents a process to assess and control elemental impurities in the drug product using
the principles of risk management as described in ICH Q9. This process provides a platform for
developing a risk-based control strategy to limit elemental impurities in the drug product.

Download PDF here

Continue at: https://www.ema.europa.eu/documents/scientific-guideline/ich-guideline-q3d-r1-elemental-impurities-step-2b_en.pdf

The text above is owned by the site above referred.

Here is only a small part of the article, for more please follow the link

Also see:

https://dadoswebaxx.weebly.com/

 

DadosWebaxx
DadosWebAxx

Leave a Reply

Your email address will not be published. Required fields are marked *